Leonard Saltz, MD
Enriched profileHead, Colorectal Oncology Section; Executive Director for Clinical Value and Sustainability · Memorial Sloan Kettering Cancer Center
Leonard Saltz is Head, Colorectal Oncology Section; Executive Director for Clinical Value and Sustainability at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 958 publications with 86,391 citations (h-index 144); ClinicalTrials.gov lists 22 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Medical Oncology profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Leonard Saltz, MD, is Head, Colorectal Oncology Section at Memorial Sloan Kettering Cancer Center. The public record shows 958 publications with 86,391 citations (h-index 144), centered on Colorectal Cancer Treatments and Studies, Colorectal Cancer Surgical Treatments, Genetic factors in colorectal cancer. It also documents an investigator role on 22 registered clinical trials, 1 NIH-funded awards (1998–2000).
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Colorectal Cancer Treatments and Studies
- 22 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 31 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 453.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →drugpricinglab.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cbsnews.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 22 registered studies on ClinicalTrials.gov. The most recent:
- A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
Sponsor: Taiho Oncology, Inc.
- Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
60.5%Proton pump inhibitor46.1%Pantoprazole Sodium100%Part D<11 patientsCorticosteroid14.5%Prednisone100%Part D<11 patientsNervous system
39.5%Atypical Antipsychotic39.5%Olanzapine100%Part D≥27 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 1998–2000 per NIH RePORTER. The latest:
- MOLECULAR PROGNOSTIC INDICATORS IN COLORECTAL CANCER
Sloan-Kettering Institute for Cancer Res
FY2000$258,040R01CA078623 - MOLECULAR PROGNOSTIC INDICATORS IN COLORECTAL CANCER
Sloan-Kettering Institute for Cancer Res
FY1999R01CA078623 - MOLECULAR PROGNOSTIC INDICATORS IN COLORECTAL CANCER
Sloan-Kettering Institute for Cancer Res
FY1998R01CA078623
Congress activity
Updated 27 Aug 2026
202 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Implementation of <i>DPYD</i> genotyping in response to FDA black box warning: Initial experience at a comprehensive cancer center.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.
Clinical cancer research
Article2026 - What Is the Cost Impact of Second Opinions in Oncology? A Retrospective Review.
JCO oncology practice
Article2025 - Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear.
Journal of clinical oncology
Letter2025 - Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait.
Diseases of the colon and rectum
Article2025
Most-cited works
by citation count (OpenAlex)- 01Tumor mutational load predicts survival after immunotherapy across multiple cancer typesArticle4,420 citations2019
- 02
- 03Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerArticle3,017 citations2000
- 04
- 05OncoKB: A Precision Oncology Knowledge BaseArticle2,738 citations2017
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/leonard-saltz-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Yale University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board certified
Medical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board certified
Hematology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership roles
journal and society appointments- Panel Member
NCCN Colon Cancer Clinical Practice Guidelines
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →www2.tri-kobe.org ↗ - Chair
Pharmacy and Therapeutics Committee, Memorial Sloan Kettering Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Chief
Gastrointestinal Medical Oncology Service, Memorial Sloan Kettering Cancer Center (5-year tenure; succeeded by Yelena Y. Janjigian, MD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.weill.cornell.edu ↗
Media & interviews
press, podcasts and appearances- Featured in CBS 60 Minutes segment "The Cost of Cancer Drugs" (aired Oct. 5, 2014)
discussing MSK's rejection of Zaltrap over pricing and "financial toxicity" to patients
2014verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cbsnews.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radiolab.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center